Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study

Post-marketing surveillance activities are essential to detect the risk/benefit profile of biologic disease-modifying antirheumatic drugs (bDMARDs) in inflammatory arthritis. The aim of this study was to evaluate adverse events (AEs) in patients treated with bDMARDs in rheumatology during a prospect...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Med
Auteurs principaux: Barbieri, Maria Antonietta, Cicala, Giuseppe, Cutroneo, Paola Maria, Gerratana, Elisabetta, Palleria, Caterina, De Sarro, Caterina, Vero, Ada, Iannone, Luigi, Manti, Antonia, Russo, Emilio, De Sarro, Giovambattista, Atzeni, Fabiola, Spina, Edoardo
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7230621/
https://ncbi.nlm.nih.gov/pubmed/32344563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9041227
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires